SENTI BIOSCIENCES
Senti Biosciences is a developer of a programmable biology platform for cancer therapies. Its therapeutics specialize in cell engineering and biological programming to build the future of gene and cell-based therapies that enable physicians to give patients life-saving treatments at an affordable cost.
SENTI BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.sentibio.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
215.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Font Awesome Apache Nginx Amazon IPv6
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
8VC
8VC investment in Post-IPO Equity - Senti Biosciences
Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy investment in Post-IPO Equity - Senti Biosciences
Leaps by Bayer
Leaps by Bayer investment in Post-IPO Equity - Senti Biosciences
Morgan Stanley Investment Management
Morgan Stanley Investment Management investment in Post-IPO Equity - Senti Biosciences
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - Senti Biosciences
Invus
Invus investment in Post-IPO Equity - Senti Biosciences
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Senti Biosciences
Amgen Ventures
Amgen Ventures investment in Post-IPO Equity - Senti Biosciences
Leaps by Bayer
Leaps by Bayer investment in Convertible Note - Senti Biosciences
National Cancer Institute
National Cancer Institute investment in Grant - Senti Biosciences
Key Employee Changes
Official Site Inspections
http://www.sentibio.com Semrush global rank: 4 M Semrush visits lastest month: 3.11 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Senti Biosciences"
Board of Directors - Senti Bio
He started its Asia business as the initial employee in 2007, and launched and co-managed the York Asian Opportunities Master Fund. Mr. Hsiung is a member of the Young Presidentsโ โฆSee details»
Home - Senti Bio
Senti Bio is a clinical-stage company founded to create a new generation of smarter medicines for patients living with incurable diseases. To achieve this, we use synthetic biology to design and optimize proprietary Gene Circuits.See details»
Overview - Senti Bio
New Medicines Require a New Way of Thinking Our Mission Senti Bio was founded to create a new generation of smarter medicines that outsmart complex diseases using novel and โฆSee details»
Scientific Advisory Board - Senti Bio
Most recently he was the Chief Commercial Officer at Seagen, leading the organization for the launches of PADCEV (enfortumab vedotin) and Tukysa (tucatinib). He began his career at โฆSee details»
Senti Biosciences - Crunchbase Company Profile & Funding
Contact Email [email protected] Senti Biosciences is a biotechnology company focused on synthetic biology and gene circuit engineering for therapeutic applications. Senti Bio utilizes a โฆSee details»
Senti Bio Appoints Feng Hsiung to Board of Directors
Mar 13, 2025 He started its Asia business as the initial employee in 2007, and launched and co-managed the York Asian Opportunities Master Fund. Mr. Hsiung is a member of the Young โฆSee details»
Senti Biosciences | Careers
Join Senti Bio and help build the next generation therapeutics. We are driven to create medicines that are programmable, controllable and designed to tackle even the most challenging โฆSee details»
Senti Bio Appoints Feng Hsiung to Board of Directors
Mar 13, 2025 He started its Asia business as the initial employee in 2007, and launched and co-managed the York Asian Opportunities Master Fund. Mr. Hsiung is a member of the Young โฆSee details»
Senti Biosciences | Careers - careers.sentibio.com
Join Senti Bio and help build the next generation therapeutics. We are driven to create medicines that are programmable, controllable and designed to tackle even the most challenging โฆSee details»
Leaps by Bayer
Leaps by Bayer's vision is to solve 10 of the world's biggest challenges through scientific breakthrough.See details»
Senti Bio Appoints Feng Hsiung to Board of Directors
Mar 13, 2025 Mr. Hsiung is a member of the Young Presidentsโ Organization since 2013 and the President of Raising Investment Corporation, the holding company for his family interests in โฆSee details»
Senti Bio - Overview, News & Similar companies | ZoomInfo.com
May 9, 2024 Senti Bio contact info: Phone number: (650) 382-3281 Website: www.sentibio.com What does Senti Bio do? Founded in 2016 and headquartered in South San Francisco, โฆSee details»
About - Senti Bio
Contact. 2 Corporate Drive, First Floor South San Francisco, CA 94080. Follow Legal. Terms of UseSee details»
Senti Bio Strengthens Leadership Team with Strategic Hires
Feb 25, 2025 โ Jay Cross, proven financial leader, appointed as CFO to drive strategic growth โ โ Faraz Siddiqui, expert in manufacturing operations, joins as SVP Technical Operations โ โฆSee details»
Senti Bio Appoints Fran Schulz to Board of Directors
Dec 2, 2024 Investors and others should note that we communicate with our investors and the public using our company website (www.sentibio.com), including, but not limited to, company โฆSee details»
Senti Biosciences - Company Profile - Tracxn
Feb 21, 2025 Senti Biosciences - Developer of cell-based therapies for cancer treatment. Public Company. Raised a total funding of $158M over 5 rounds from 31 investors. Founded by Tim โฆSee details»
Team - Senti Bio
Mr. Chung joined Senti Bio in 2022 and brings 15 years of investing, operations, board and advisory experience from a broad set of industries including life sciences, healthcare, โฆSee details»
Senti Bio Company Profile | Management and Employees List
SQL International Organization for Standardization . HTML Web Hypertext Application Technology Working Group . Python Python . CSS World Wide Web Consortium . PHP PHP . โฆSee details»
Senti Biosciences - Work in biotech
Senti Biosciences is outsmarting complex diseases by developing intelligent medicines using synthetic biology. Senti Bio designs and optimizes gene circuits, created from novel and โฆSee details»
Senti Bio Appoints Fran Schulz to Board of Directors
Dec 2, 2024 Biotechnology industry executive with a proven track record of advising management teams on corporate and financial strategy for more than 30 yearsSOUTH SAN โฆSee details»